Home »
Academic Articles »
C »
Deep learning prediction of pathological complete response in breast cancer using Mamba architecture
Deep learning prediction of pathological complete response in breast cancer using Mamba architecture
Wenchuan Zhang
(Department of Pathology, West China Hospital, Sichuan University)
Shuwan Zhang
(Department of Pathology, Shengjing Hospital of China Medical University)
Fengling Li
(Department of Pathology, West China Hospital, Sichuan University)
Yuanyuan Zhao
(Department of Pathology, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University)
Jing Fu
(Department of Pathology, Sichuan Provincial People’s Hospital)
Xiuli Xiao
(Department of Pathology, The Affiliated Hospital of Southwest Medical University)
Ting Yin
(Department of Pathology, West China Hospital, Sichuan University)
Qingjie Lv
(Department of Pathology, Shengjing Hospital of China Medical University)
Yuhao Yi
(Department of Pathology, West China Hospital, Sichuan University)
Hong Bu
(Department of Pathology, West China Hospital, Sichuan University)
Journal: npj Digital Medicine
•
• Nature Portfolio
• ISSN: 2398-6352
Abstract
Abstract Deep learning is capable of efficiently predicting the therapeutic efficacy of neoadjuvant chemotherapy (NAC) in breast cancer. However, current methods predominantly rely on convolutional neural networks or transformer architectures and are often validated in small patient cohorts. We developed a Mamba-based deep learning model for predicting chemotherapy efficacy using needle biopsy (MCEN) from 1646 patients with breast cancer across five tertiary hospitals, aiming to predict pathological complete response following NAC. We randomly divided 1023 biopsy samples from one hospital into training and validation sets at an 8:2 ratio and used the remaining four hospitals as external test sets to evaluate the model’s performance and robustness. In the training and validation sets, the MCEN achieved areas under the receiver operating characteristic curve (AUROCs) of 0.923 and 0.78, respectively. For the four external test sets, the MCEN achieved AUROCs ranging from 0.761– to 0.809. Incorporating clinicopathological information improved the MCEN model’s predictive performance, achieving AUROCs of 0.937 and 0.811 in the training and validation sets, respectively, and ranging from 0.773– to 0.84 in the external test sets. Our study demonstrates the potential of the MCEN as a valuable tool in clinical decision-making.
Wenchuan Zhang, Shuwan Zhang, Fengling Li, et al. (2026). "Deep learning prediction of pathological complete response in breast cancer using Mamba architecture". npj Digital Medicine. https://doi.org/10.1038/s41746-026-02849-2